Biotech Series B Investors & VC Firms
724 firms in this list, with a median first check of $500K. 165 of them lead rounds. Generated from verified public data and updated continuously.
New Business Venture Fund
ReykjavíkSeed–Series B$216K – $4.3M
4 people
Capstone Partners Korea
SeoulSeed–Series B
Mammoth Research
Fort WayneSeries A–Growth
9 people
Matrix Partners China
BeijingSeed–Late Stage
3 people
ODYSSEE VENTURE
ParisSeries A–Late Stage$1.1M – $11M
3 people
Overmatch
AustinSeed–Series B$2M
3 people
Axil Capital
TokyoSeed–Late Stage
7 people
Siana Capital Management
BangaloreSeries A–Series B$1M – $3M
5 people
Build Ventures
HalifaxSeed–Series C
3 people
Kolon Investment, Inc.
SeoulSeed–Late Stage
Quam Venture Capital
LondonPre-Seed–Growth$500K – $10M
6 people
Waterman Ventures
UtrechtSeed–Growth
3 people
Dalton Venture
ShanghaiSeed–Series B
8 people
Mirae Asset Venture Investment
Seed–Series B
5 people
EGORA Ventures AG
MartinsriedSeed–Series B$5.4M
6 people
InVivium Capital
ChicagoSeed–Growth
6 people
TPB
San FranciscoSeed–Late Stage
6 people
Vision Creator
SeoulSeed–Late Stage
BSK Investment
SeoulSeed–Late Stage
14 people
Clarus Ventures
Menlo ParkPre-Seed–Late Stage
8 people
IDB Lab
Washington, D.C.Pre-Seed–Series B
7 people
Monolith Venture Advisory Limited
Grand CaymanSeed–Growth
4 people
APOLLO PROJECTS
San FranciscoSeed–Series B
2 people
SBCVC
TortolaSeed–Series B
6 people
Related lists
Series B Investors & VC Firms (2951)Biotech Investors & VC Firms (2483)Biotech Seed Investors & VC Firms (2027)Series B Investors & VC Firms in North America (1738)Biotech Series A Investors & VC Firms (1627)Biotech Investors & VC Firms in North America (1601)Series B Investors & VC Firms in United States (1573)Biotech Investors & VC Firms in United States (1450)SaaS Series B Investors & VC Firms (1075)Series B Investors & VC Firms in Europe (1073)
Data sourced from public filings and firms' own websites — see our methodology.





















































